Strategic Partnerships

News
Webcast

Webcasts

Webinar Date/Time: Fri, Mar 21, 2025 11:00 AM EDT

Find out more about the key drivers that are shaping the bio/pharma outsourcing market. Additionally, learn about the benefits of integrated services and potential trends that will impact the outsourcing sector in the near future.

Register Free: https://www.pharmtech.com/pt_w/strategic-partnerships

Event Overview:

In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about strategic partnerships in the bio/pharma industry. During the discussion, various experts will detail how the bio/pharma outsourcing market has evolved, how service providers have adapted to meet the shifting industry demands, the benefit of ‘integrated services’ and the potential challenge to providing such services while also being flexible, and potential trends that may shape the outsourcing market in the coming years.
Interviews featuring:

This episode of Drug Digest is sponsored by:

  • Adare
  • August Bioservices
  • Catalent
  • Coating Place
  • LabVantage

Key Learning Objectives:

  • Learn about the driving trends shaping the bio/pharma outsourcing market.
  • Understand the benefits of integrated services.
  • Discover how flexible strategies can help service providers meet new demands.
  • Learn about potential future trends for outsourced services.

Who Should Attend:

  • CDMOs
  • CMOs
  • Quality personnel
  • Consultants

Speaker:

John McQuaid
President and Managing Director
Almac Pharma Services


John
first joined Almac Group in 1994 and has held a number of management roles during his tenure. In 2011 he was appointed to Vice President of Technical Operations within Almac Pharma Services where he was responsible for overseeing the strategic growth and development of the Pharmaceutical Development & Manufacturing service offering.


John, who holds a BSc Honours degree, was promoted to President and Managing Director, Almac Pharma Services, in 2022 and is responsible for the strategic, financial and operational leadership of global business. He has extensive product development, quality assurance and validation experience with direct experience of hosting product pre-approval inspections by multiple regulatory authorities.

Register Free: https://www.pharmtech.com/pt_w/strategic-partnerships

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Related Content